Journal article
Neuronal ceroid lipofuscinosis type 2: an Australian case series
AM Johnson, S Mandelstam, I Andrews, K Boysen, J Yaplito-Lee, M Fietz, L Nagarajan, V Rodriguez-Casero, MM Ryan, N Smith, IE Scheffer, C Ellaway
Journal of Paediatrics and Child Health | WILEY | Published : 2020
DOI: 10.1111/jpc.14890
Open access
Abstract
Aim: Late infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease is a rare neurodegenerative disorder presenting in children aged 2–4 years with seizures and loss of motor and language skills, followed by blindness and death in late childhood. Initial presenting features are similar to a range of common epilepsies. We aim to highlight typical clinical and radiological features that may prompt diagnosis of CLN2 disease in early disease stages. Methods: We present a series of 13 Australian patients with CLN2 disease, describing clinical features, disease evolution, neuroimaging, electroencephalogram, biochemical and genetic results. Expert neuroradiological magnetic resonance imaging (..
View full abstractGrants
Funding Acknowledgements
Writing support was provided by Emma Conran, Porterhouse Medical, Reading, UK, and funded by BioMarin Pharmaceutical Inc.